Hydroxychloroquine in the Treatment of Malaria

Miguel Nieto-Caicedo Division of Malariology, Department of Public Health and Social Welfare, Venezuela

Search for other papers by Miguel Nieto-Caicedo in
Current site
Google Scholar
PubMed
Close
Restricted access

Summary

Hydroxychloroquine was given orally to 50 patients with P. vivax infections, either in a single dose or in a one-day treatment of several doses. Both parasitemia and temperature were controlled on the average in less than 2 days, with no unfavorable effects noted. This study in Venezuela confirms observations by others that hydroxychloroquine exhibits antimalarial activity against P. vivax comparable to that of other 4-aminoquinolines but appears to be better tolerated.

Author Notes

Past two years Past Year Past 30 Days
Abstract Views 665 233 12
Full Text Views 55 2 0
PDF Downloads 56 4 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save